Literature DB >> 28965333

Preliminary identification of key miRNAs, signaling pathways, and genes associated with Hirschsprung's disease by analysis of tissue microRNA expression profiles.

Zhi-Gang Gao1, Qing-Jiang Chen1, Min Shao2, Yun-Zhong Qian3, Li-Feng Zhang1, Yue-Bin Zhang1, Qi-Xing Xiong1.   

Abstract

BACKGROUND: Hirschsprung's disease (HSCR) is a congenital gut motility disorder of infants, and if left untreated, it is fatal to the affected infants. This study aimed to identify key microRNAs (miRNAs), signaling pathways and genes involved in the pathogenesis of HSCR.
METHODS: The miRNA microarray dataset GSE77296 was downloaded. Nine colon tissue samples were available: six from HSCR patients and three matched control samples. Differentially expressed miRNAs (DEMs) were identified after data preprocessing. Target genes of the selected upregulated and downregulated DEMs were predicted. In addition, functional enrichment analyses for the selected DEMs and target genes were conducted. Finally, interaction networks between the DEMs and target genes were constructed.
RESULTS: A total of 162 DEMs (73 upregulated and 89 downregulated) were obtained. A total of 2511 DEM-target gene pairs for the 40 selected DEMs were identified, including 1645 pairs for the upregulated DEMs and 866 pairs for the downregulated DEMs. The upregulated DEM miR-141-3p and down-regulated DEM miR-30a-3p were identified as key miRNAs by Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment and network analyses. Besides, KEGG pathway enrichment analysis revealed that pathways in cancer and the mitogen-activated protein kinase (MAPK) signaling pathway were key pathways. The key genes frizzled class receptor 3 (FZD3) and docking protein 6 (DOK6) were obtained through the DEM-target gene interaction networks.
CONCLUSION: Two key miRNAs (miR-141-3p and miR-30a-3p), the MAPK signaling pathway and two key genes (FZD3 and DOK6) were implicated in the pathogenesis of HSCR.

Entities:  

Keywords:  Hirschsprung’s disease; differentially expressed microRNA; docking protein 6; frizzled class receptor 3; mitogen-activated protein kinase signaling pathway

Mesh:

Substances:

Year:  2017        PMID: 28965333     DOI: 10.1007/s12519-017-0064-z

Source DB:  PubMed          Journal:  World J Pediatr            Impact factor:   2.764


  33 in total

1.  KEGG: kyoto encyclopedia of genes and genomes.

Authors:  M Kanehisa; S Goto
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  Cytoscape: a software environment for integrated models of biomolecular interaction networks.

Authors:  Paul Shannon; Andrew Markiel; Owen Ozier; Nitin S Baliga; Jonathan T Wang; Daniel Ramage; Nada Amin; Benno Schwikowski; Trey Ideker
Journal:  Genome Res       Date:  2003-11       Impact factor: 9.043

3.  clusterProfiler: an R package for comparing biological themes among gene clusters.

Authors:  Guangchuang Yu; Li-Gen Wang; Yanyan Han; Qing-Yu He
Journal:  OMICS       Date:  2012-03-28

4.  Variants in RET associated with Hirschsprung's disease affect binding of transcription factors and gene expression.

Authors:  Yunia Sribudiani; Marco Metzger; Jan Osinga; Amanda Rey; Alan J Burns; Nikhil Thapar; Robert M W Hofstra
Journal:  Gastroenterology       Date:  2010-10-25       Impact factor: 22.682

5.  Fzd3 and Fzd6 deficiency results in a severe midbrain morphogenesis defect.

Authors:  Sebastian Stuebner; Theresa Faus-Kessler; Thomas Fischer; Wolfgang Wurst; Nilima Prakash
Journal:  Dev Dyn       Date:  2010-01       Impact factor: 3.780

6.  miR-141-3p inhibits human stromal (mesenchymal) stem cell proliferation and differentiation.

Authors:  Weimin Qiu; Moustapha Kassem
Journal:  Biochim Biophys Acta       Date:  2014-06-14

7.  Aberrant reduction of MiR-141 increased CD47/CUL3 in Hirschsprung's disease.

Authors:  Weibing Tang; Jingjing Qin; Junwei Tang; Hongwei Zhang; Zhigang Zhou; Bo Li; Qiming Geng; Wei Wu; Yankai Xia; Xiaoqun Xu
Journal:  Cell Physiol Biochem       Date:  2013-12-05

8.  Role of MiR-215 in Hirschsprung's Disease Pathogenesis by Targeting SIGLEC-8.

Authors:  Hao Lei; Hongxing Li; Hua Xie; Chunxia Du; Yankai Xia; Weibing Tang
Journal:  Cell Physiol Biochem       Date:  2016-12-23

9.  Decreased MiR-200a/141 suppress cell migration and proliferation by targeting PTEN in Hirschsprung's disease.

Authors:  Hongxing Li; Junwei Tang; Hao Lei; Peng Cai; Hairong Zhu; Bo Li; Xiaoqun Xu; Yankai Xia; Weibing Tang
Journal:  Cell Physiol Biochem       Date:  2014-08-08

10.  miR-200bc/429 cluster targets PLCgamma1 and differentially regulates proliferation and EGF-driven invasion than miR-200a/141 in breast cancer.

Authors:  S Uhlmann; J D Zhang; A Schwäger; H Mannsperger; Y Riazalhosseini; S Burmester; A Ward; U Korf; S Wiemann; O Sahin
Journal:  Oncogene       Date:  2010-05-31       Impact factor: 9.867

View more
  4 in total

1.  Differential expression of miR-4492 and IL-10 is involved in chronic rhinosinusitis with nasal polyps.

Authors:  Linge Li; Juan Feng; Dinghao Zhang; Jun Yong; Yan Wang; Jianfeng Yao; Rongfu Huang
Journal:  Exp Ther Med       Date:  2019-09-18       Impact factor: 2.447

2.  Associations between common genetic variants in microRNAs and Hirschsprung disease susceptibility in Southern Chinese children.

Authors:  Qi Wu; Jinglu Zhao; Yi Zheng; Xiaoli Xie; Qiuming He; Yun Zhu; Ning Wang; Lihua Huang; Lifeng Lu; Tuqun Hu; Jixiao Zeng; Huimin Xia; Yan Zhang; Wei Zhong
Journal:  J Gene Med       Date:  2021-01-07       Impact factor: 4.565

3.  Association between ABHD1 and DOK6 polymorphisms and susceptibility to Hirschsprung disease in Southern Chinese children.

Authors:  Chaoting Lan; Yuxin Wu; Ning Wang; Yun Luo; Jinglu Zhao; Yi Zheng; Yan Zhang; Lihua Huang; Yun Zhu; Lifeng Lu; Wei Zhong; Jixiao Zeng; Huimin Xia
Journal:  J Cell Mol Med       Date:  2021-09-20       Impact factor: 5.310

4.  Association between IKBKAP polymorphisms and Hirschsprung's disease susceptibility in Chinese children.

Authors:  Ning Wang; Jiaojiao Xi; Chaoting Lan; Yuxin Wu; Yun Zhu; Xiaoyu Zuo; Yan Zhang
Journal:  Transl Pediatr       Date:  2022-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.